Searched for
JB PHARMA Q1 FY25 RESULTS
Goldman Sachs upgrades India's growth outlook after US-Iran peace dealGoldman Sachs has raised India's 2026 real GDP growth forecast to 6.8% from 6.5%, citing lower oil prices, easing supply disruptions and re...- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- Affordable housing finance firms likely to regain growth in FY27, but macro risks loom: KotakAffordable housing finance companies are poised for a growth rebound from FY27, according to Kotak Institutional Securities. After a subdue...
- ET Prime Special Series: Multibagger or IBC - Part 64: An old 2-wheeler supplier that now earns more from a newer businessAt first glance, this auto ancillary company looks like a conventional two-wheeler supplier. But its business mix tells a wider story. A ne...
- India's office market remains cautious despite resilient demand and selective rental gains: ReportIndia's office market saw demand outpace new supply in Q2 FY26, leading to modest rent increases in active areas. Despite a cautious overal...
- Buy, Sell or Hold: Goldman Sachs maintains sell on Bharat Dynamics; HDFC Securities maintains buy on IndiaMART InterMESHBrokerages remain divided on two stocks. Goldman Sachs retained its 'Sell' rating on Bharat Dynamics, raising the target price marginally t...
- Trent shares jump 4% after Noel Tata’s comments during AGM. Here’s what Morgan Stanley, other brokerages sayTrent's stock surged over 4% as brokerages like Morgan Stanley and Motilal Oswal reiterated bullish calls. Chairman Noel Tata's vision of 1...
- India's services exports narrow gap with goods trade as overall trade grows 5.4% in Q4FY26: NITI AayogIndia's trade saw a healthy 5.4% growth in Q4 FY26, driven by robust services exports that significantly boosted the services trade surplus...
- PSU banks lose gold loan sourcing share as private banks, NBFCs gain traction: ReportPublic sector banks are losing ground in the gold loan market to private lenders and NBFCs, which offer faster service and wider reach. Whi...
- Meesho shares rise 2% as Citi initiates coverage with Buy rating. Here's whyInternational brokerage Citi initiated coverage on Meesho with a 'Buy' rating, setting a target price of Rs 210 and anticipating a 23% upsi...
- Bharat Electronics shares in focus after defence PSU wins orders worth Rs 1,081 croreBharat Electronics shares are in focus following a significant Rs 1,081 crore order win, adding to previous gains. The defence PSU reported...
- TCS to kickstart Q1 earnings on July 9, sets record date for potential dividendTCS will kick off the Q1FY27 earnings season on July 9, with its board set to consider an interim dividend alongside quarterly results. Inv...
- Tata Capital shares slip 3% after stock rallies 17% in one week to lifetime high. What’s ahead?Tata Capital shares saw a dip on Monday following a significant rally that propelled them to an all-time high last week. Despite a recent s...
- Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...
- Earnings of OMCs seen weak as Q1FY27 under-recoveries bite: ReportOil companies are projected to experience ongoing challenges through FY27, primarily due to anticipated under-recoveries in Q1FY27, with LP...
- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
- ICICI Prudential AMC shares fall 2% as IPO lock-in expiry frees up Rs 1.2 lakh crore stake for tradeICICI Prudential AMC shares dropped 2% to Rs 513 as 34.4 crore shares became eligible for trade post IPO lock-in expiry. The company's stoc...
- Buy, Sell or Hold: Morgan Stanley raises target price on NYKAA; Elara Capital maintains buy on Devyani InternationalBrokerage views on Indian equities are mixed as Morgan Stanley raises Nykaa's target price on ambitious FY30 growth plans. Conversely, conc...
- Mobikwik shares in focus as IPO lock-in expiry frees up stake worth Rs 317 crore for tradeThe shares of the fintech platform had made a solid market debut in December, 2024, listing with nearly 59% premium over the IPO price at R...
- Dividend alert! Last date to buy Tata Tech, HDB Financial, 6 other stocks for dividends worth Rs 36The shares of Tata Technologies on Thursday will turn ex-record date for a special dividend of Rs 3.35 per share and a final dividend of Rs...
Load More
